Disorders of immune dysregulation

Gene: STXBP2

Green List (high evidence)

STXBP2 (syntaxin binding protein 2, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000076944
EnsemblGeneIds (GRCh37): ENSG00000076944
OMIM: 601717, ClinGen, DECIPHER
STXBP2 is in 11 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

PMID 25564401: four unrelated families (P1‑P4) harbouring heterozygous (monoallelic) or biallelic STXBP2 miss‑sense variants at codon 65 (R65Q or R65W) that cause familial haemophagocytic lymphohistiocytosis (F‑HLH). Functional assays (patient CTL/NK cytotoxicity, degranulation, forced expression in control cells, liposome‑fusion assays) demonstrate that the R65Q/W mutants act in a dominant‑negative manner to inhibit SNARE‑complex assembly and membrane fusion. Two families carry heterozygous variants (monoallelic disease) and two families carry biallelic variants (homozygous R65Q or compound‑heterozygous R65Q + G541S).

Insufficient evidence for monoallelic MOI except for variants at this specific codon.
Created: 13 Aug 2026, 2:34 p.m. | Last Modified: 13 Aug 2026, 2:34 p.m.
Panel Version: 2.8
Well established gene-disease association.
Created: 23 Mar 2022, 4:22 p.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Haemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease 613101

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Melbourne Genomics Health Alliance Immunology Flagship
  • Victorian Clinical Genetics Services
  • Victorian Clinical Genetics Services
Phenotypes
  • Haemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease MIM#613101
OMIM
601717
ClinGen
STXBP2
DECIPHER
STXBP2
Clinvar variants
Variants in STXBP2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
13 Aug 2026, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: STXBP2 were set to 19804848

13 Aug 2026, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: stxbp2 has been classified as Green List (High Evidence).

13 Aug 2026, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: STXBP2 were changed from to Haemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease MIM#613101

13 Aug 2026, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: STXBP2 were set to

13 Aug 2026, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: STXBP2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

18 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: STXBP2 was added gene: STXBP2 was added to Disorders of immune dysregulation_MGHA_AGHA_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: STXBP2 was set to Unknown